SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-038413
Filing Date
2021-02-11
Accepted
2021-02-11 16:06:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d116382dsc13g.htm SC 13G 34355
  Complete submission text file 0001193125-21-038413.txt   35712
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Subject) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-91717 | Film No.: 21619629
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRELUDE THERAPEUTICS INCORPORATED 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address
Vaddi Krishna (Filed by) CIK: 0001824633 (see all company filings)

Type: SC 13G